Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lenting

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Blood Advances|May 13, 2020
Laboratory monitoring of hemophilia A treatments: new challengesPeter J Lenting
Blood|November 15, 2011
SHEARiO, fast lane to oxidized VWFPeter J Lenting
Hamostaseologie|January 30, 2019
Antibodies in the Treatment of Haemophilia A-A Biochemical PerspectiveStephen Ferrière, Peter J Lenting
Blood Advances|October 8, 2024
Gene therapy for hemophiliaPeter J Lenting, Sylvia Fong
Haematologica|November 25, 2021
How to keep the factor VIII/von Willebrand factor complex in the circulationCécile V Denis, Peter J Lenting
International Journal of Hematology|April 6, 2012
von Willebrand factor: at the crossroads of bleeding and thrombosisCécile V Denis, Peter J Lenting
Blood|February 24, 2018
VWF clearance: it's glycomplicatedCécile V Denis, Peter J Lenting
Blood|December 17, 2013
Platelet von Willebrand factor: sweet resistancePeter J Lenting, Cécile V Denis
Journal of Thrombosis and Haemostasis : JTH|September 18, 2020
Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19: Response from Original Authors Susen, et alSophie Susen, Antoine Rauch, Peter J Lenting
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Emicizumab and thrombosis: The story so farMichael Makris, Alfonso Iorio, Peter J Lenting
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Blood Advances|May 13, 2020
Laboratory monitoring of hemophilia A treatments: new challengesPeter J Lenting
Blood|November 15, 2011
SHEARiO, fast lane to oxidized VWFPeter J Lenting
Hamostaseologie|January 30, 2019
Antibodies in the Treatment of Haemophilia A-A Biochemical PerspectiveStephen Ferrière, Peter J Lenting
Blood Advances|October 8, 2024
Gene therapy for hemophiliaPeter J Lenting, Sylvia Fong
Haematologica|November 25, 2021
How to keep the factor VIII/von Willebrand factor complex in the circulationCécile V Denis, Peter J Lenting
International Journal of Hematology|April 6, 2012
von Willebrand factor: at the crossroads of bleeding and thrombosisCécile V Denis, Peter J Lenting
Blood|February 24, 2018
VWF clearance: it's glycomplicatedCécile V Denis, Peter J Lenting
Blood|December 17, 2013
Platelet von Willebrand factor: sweet resistancePeter J Lenting, Cécile V Denis
Journal of Thrombosis and Haemostasis : JTH|September 18, 2020
Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19: Response from Original Authors Susen, et alSophie Susen, Antoine Rauch, Peter J Lenting
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Emicizumab and thrombosis: The story so farMichael Makris, Alfonso Iorio, Peter J Lenting
Pageof 17